Scientific publications
Adipose Tissue Inflammation
Javier Gómez-Ambrosi 1 2 3
In recent decades, obesity has become one of the most common metabolic diseases. Excess adiposity increases the risk of developing type 2 diabetes (T2D), cardiometabolic diseases, dyslipidemia, fatty liver, and several types of cancer [1]. Much progress has been made in understanding the major regulatory pathways underlying adipose tissue inflammation, which represent one the main drivers of adipose tissue dysfunction and, consequently, of obesity-associated metabolic alterations [2].
This Special Issue presents recent advances in understanding the molecular processes that take place in adipose tissue inflammation; moreover, it discusses the impact of adipose tissue inflammation on systemic metabolic alterations associated with excess adiposity, as well as its repercussion in several pathological conditions.
CITATION Cells. 2023 May 26;12(11):1484. doi: 10.3390/cells12111484
Our authors
